Ganciclovir Ophthalmic Gel 0.15% W/W

CIPVISION GIVOSIRUN is a sterile ophthalmic gel containing Ganciclovir Ophthalmic Gel 0.15% W/W, an antiviral medication used for the treatment of specific viral eye infections. It is primarily prescribed for acute herpetic keratitis, a corneal infection caused by the herpes simplex virus (HSV). The gel works by inhibiting viral DNA replication, thereby preventing the virus from multiplying and allowing the infected corneal tissue to heal. Its gel-based formulation provides prolonged contact with the eye surface, ensuring effective drug delivery while minimizing frequent application. CIPVISION GIVOSIRUN should always be used under the supervision of an ophthalmologist for optimal safety and effectiveness.

Uses

CIPVISION GIVOSIRUN is commonly prescribed for:

• Treatment of acute herpetic keratitis (dendritic corneal ulcers) caused by herpes simplex virus.
• Reducing viral replication in infected corneal tissue.
• Promoting faster healing of corneal lesions.
• Helping relieve symptoms such as eye pain, redness, irritation, tearing, and sensitivity to light.
• Preventing the progression of viral eye infections when used as directed by an eye specialist.

Benefits

CIPVISION GIVOSIRUN offers several therapeutic advantages, including:

• Effectively targets herpes simplex virus in the eye.
• Accelerates healing of corneal ulcers and lesions.
• Helps reduce eye discomfort, redness, and inflammation associated with viral infections.
• Gel formulation provides extended contact time with the ocular surface for enhanced efficacy.
• Minimizes the risk of worsening infection when treatment is initiated promptly.
• Generally well tolerated with minimal systemic absorption.
• Supports restoration of normal corneal health under medical supervision.

Dosage

Use CIPVISION GIVOSIRUN exactly as prescribed by your ophthalmologist.

• Wash your hands thoroughly before applying the gel.
• Instill one drop into the affected eye as directed by your healthcare provider.
• Avoid touching the tip of the tube to the eye or any surface to prevent contamination.
• Continue treatment for the complete prescribed duration, even if symptoms improve earlier.
• If using other eye medications, maintain an interval of at least 510 minutes between applications.

Do not discontinue treatment without consulting your doctor.

Side Effects

Like all medicines, CIPVISION GIVOSIRUN may cause some side effects, although not everyone experiences them.

Common side effects include:

• Temporary blurred vision after application
• Mild burning or stinging sensation
• Eye irritation
• Watery eyes
• Redness of the eye
• Mild eye discomfort
• Temporary sensitivity to light

Seek immediate medical attention if severe allergic reactions, persistent eye pain, vision changes, or worsening symptoms occur.

Precautions and Warnings

Before using CIPVISION GIVOSIRUN, consider the following precautions:

• Use only as prescribed by an ophthalmologist.
• Do not wear contact lenses during active eye infection unless advised by your doctor.
• Avoid contaminating the applicator tip.
• Inform your doctor about any allergies or previous eye disorders.
• Tell your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
• Avoid driving or operating machinery immediately after application if temporary blurred vision occurs.
• Store the product according to the manufacturer's instructions and keep it out of reach of children.
• Never share your eye medication with others.

Conclusion

CIPVISION GIVOSIRUN (Ganciclovir Ophthalmic Gel 0.15% W/W) is a trusted antiviral ophthalmic formulation designed for the effective management of acute herpetic keratitis caused by the herpes simplex virus. By inhibiting viral replication, it promotes faster healing of corneal lesions while relieving discomfort and protecting ocular health. When used exactly as prescribed by an eye specialist, CIPVISION GIVOSIRUN provides targeted, effective, and well-tolerated treatment for viral eye infections, helping patients recover safely and maintain healthy vision.